Combined hormonal contraception: reasons for refusal and use in high-risk women
https://doi.org/10.33667/2078-5631-2022-24-27-30
Abstract
Purpose: the article discusses the possibility of using combined hormonal contraception, the reasons for refusal and the use in women of high-risk groups.
Methods: a review of data for 5 years was carried out, the factors that led to the refusal to use this type of contraception were analyzed. Information has been collected on the guidelines for action in patients with a high risk of side effects using combined hormonal contraception.
Conclusions: women’s fear of adverse events, the formation of health problems, are one of the main reasons for refusing to use contraceptives or completely stopping their use. Future research should explore user bias towards hormonal contraception for a better understanding of birth control, better matching the needs and expectations of women and men today.
About the Author
E. N. Kravchenko
Omsk State Medical University
Russian Federation
Russian Federation
Kravchenko Elena N., DM Sci (habil.), professor, professor of the Department of Obstetrics and Gynecology of the 1st Federal State Budgetary Educational Institution of Higher Education
Omsk
References
1. Abbe CR, Page ST, Thirumalai A. Male Contraception. Yale J Biol Med. 2020 Sep 30;93(4):603–613. PMID: 33005125; PMCID: PMC 7513428.
2. Canadian Contraception Consensus (Part 2 of 4). Journal of obstetrics and gynaecology Canada: JOGC = Journal d’obstetrique et gynecologie du Canada: JOGC. Vol. 37,11 (2015): 1033–9. doi: 10.1016/s1701–2163(16)30054-8
3. Regidor Pedro-Antonio. Clinical relevance in present day hormonal contraception. Hormone molecular biology and clinical investigation. Vol. 37,1 10.1515/hmbci-2018–0030. 26 Oct. 2018. doi: 10.1515/hmbci-2018–0030
4. Teal S, Edelman A. Contraception Selection, Effectiveness, and Adverse Effects: A Review. JAMA. 2021 Dec 28;326(24):2507–2518. doi: 10.1001/jama.2021.21392. PMID: 34962522.
5. Brown EJ, Deshmukh P, Antell K. Contraception Update: Oral Contraception. FP Essent. 2017 Nov;462:11–19. PMID: 29172411.
6. Le Guen, Mireille et al. Reasons for rejecting hormonal contraception in Western countries: A systematic review. Social science & medicine (1982). Vol. 284 (2021): 114247. doi: 10.1016/j.socscimed.2021.114247
7. Regidor Pedro-Antonio. The clinical relevance of progestogens in hormonal contraception: Present status and future developments. Oncotarget. Vol. 9,77 34628–34638. 2 Oct. 2018, doi: 10.18632/oncotarget.26015
8. Marsden Jo. Hormonal contraception and breast cancer, what more do we need to know? Post reproductive health. Vol. 23,3 (2017): 116–127. doi: 10.1177/2053369117715370
9. Sales Vieira C, Celis C, Galán G, Hernández L, Díaz I, López J. Drospirenone: a Latin American perspective for oestrogen-free oral contraception. Eur J Contracept Reprod Health Care. 2021 Feb;26(1):73–78. doi: 10.1080/13625187.2020.1837364. Epub 2020 Nov 6. PMID: 33155847.
10. Systematic Review of Hormonal Contraception and Risk of Venous Thrombosis. The Linacre quarterly. Vol. 85,4 (2018): 470–477. doi: 10.1177/0024363918816683
11. Lete Iñaki. Combined hormonal contraception and COVID-19. The European journal of contraception & reproductive health care: the official journal of the European Society of Contraception. Vol. 26,2 (2021): 128–131. doi: 10.1080/13625187.2020.1867845
12. Caruso Salvatore et al. Sexual activity and contraceptive use during social distancing and self-isolation in the COVID-19 pandemic. The European journal of contraception & reproductive health care: the official journal of the European Society of Contraception. Vol. 25,6 (2020): 445–448. doi: 10.1080/13625187.2020.1830965
13. Voedisch AJ, Hindiyeh N. Combined hormonal contraception and migraine: are we being too strict? Curr Opin Obstet Gynecol. 2019 Dec;31(6):452–458. doi: 10.1097/GCO.0000000000000586. PMID: 31573998.
14. McCloskey LR, Wisner KL, Cattan MK, Betcher HK, Stika CS, Kiley JW. Contraception for Women With Psychiatric Disorders. Am J Psychiatry. 2021 Mar 1;178(3):247–255. doi: 10.1176/appi.ajp.2020.20020154. Epub 2020 Nov 10. PMID: 33167674.
15. Fruzzetti Franca and Tiziana Fidecicchi. Hormonal Contraception and Depression: Updated Evidence and Implications in Clinical Practice. Clinical drug investigation. Vol. 40,12 (2020): 1097–1106. doi: 10.1007/s40261-020-00966-8
16. Both Stephanie et al. Hormonal Contraception and Female Sexuality: Position Statements from the European Society of Sexual Medicine (ESSM). The Journal of sexual medicine. Vol. 16,11 (2019): 1681–1695. doi: 10.1016/j.jsxm.2019.08.005
17. Girum T, Wasie A. Return of fertility after discontinuation of contraception: a systematic review and meta-analysis. Contracept Reprod Med. 2018 Jul 23;3:9. doi: 10.1186/s40834–018–0064-y. PMID: 30062044; PMCID: PMC 6055351.
18. Grandi Giovanni et al. Hormonal contraception in women with endometriosis: a systematic review. The European journal of contraception & reproductive health care: the official journal of the European Society of Contraception. Vol. 24,1 (2019): 61–70. doi: 10.1080/13625187.2018.1550576
19. Jensen, Jeffrey T et al. Use of combined hormonal contraceptives for the treatment of endometriosis-related pain: a systematic review of the evidence. Fertility and sterility. Vol. 110,1 (2018): 137–152.e1. Doi: 10.1016/j.fertnstert.2018.03.012
Review
For citations:
Kravchenko E.N. Combined hormonal contraception: reasons for refusal and use in high-risk women. Medical alphabet. 2022;(24):27-30. (In Russ.) https://doi.org/10.33667/2078-5631-2022-24-27-30
Views:
241
Email this article 